Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (341-350 of 403) with videos related to

Pageof 41
Sort By:
Plos One|August 11, 2017
Investigation of correlates of protection against pharyngeal carriage of Neisseria meningitidis genogroups W and Y in the African meningitis beltLaura V Cooper, Rahamatou Moustapha Boukary, Abraham Aseffa, et al.
The New England Journal of Medicine|June 2, 2021
Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian ToddlersMilagritos D Tapia, Samba O Sow, Abdi Naficy, et al.
The Pediatric Infectious Disease Journal|March 14, 2023
Antibody Persistence After Primary SARS-CoV-2 Infection and Protection Against Future Variants Including Omicron in Adolescents: National, Prospective Cohort StudyFelicity Aiano, Georgina Ireland, Frances Baawuah, et al.
Archives of Disease in Childhood|July 8, 2024
An open-label, phase IV randomised controlled trial of two schedules of a four-component meningococcal B vaccine in UK preterm infantsAnna Calvert, Nick Andrews, Sheula Barlow, et al.
The Lancet. Infectious Diseases|August 19, 2018
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled studyWilbur H Chen, Kathleen M Neuzil, C Rebecca Boyce, et al.
Human Vaccines & Immunotherapeutics|November 28, 2022
Presentations at the UK National Immunisation ConferenceAndrew J Pollard, Noni E MacDonald, Eve Dubé, et al.
Vaccine|October 10, 2020
Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolatesAlessia Biolchi, Gabriella De Angelis, Monica Moschioni, et al.
The Journal of Infection|November 5, 2019
Prevention and control of meningococcal disease: Updates from the Global Meningococcal Initiative in Eastern EuropeXilian Bai, Ray Borrow, Suzana Bukovski, et al.
Emerging Infectious Diseases|July 5, 2008
A prospective study of etiology of childhood acute bacterial meningitis, TurkeyMehmet Ceyhan, Inci Yildirim, Paul Balmer, et al.
Expert Review of Vaccines|November 9, 2016
The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protectionRay Borrow, Pedro Alarcón, Josefina Carlos, et al.
Pageof 41

Showing results (341-350 of 403) with videos related to

Sort By:
Pageof 41
Plos One|August 11, 2017
Investigation of correlates of protection against pharyngeal carriage of Neisseria meningitidis genogroups W and Y in the African meningitis beltLaura V Cooper, Rahamatou Moustapha Boukary, Abraham Aseffa, et al.
The New England Journal of Medicine|June 2, 2021
Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian ToddlersMilagritos D Tapia, Samba O Sow, Abdi Naficy, et al.
The Pediatric Infectious Disease Journal|March 14, 2023
Antibody Persistence After Primary SARS-CoV-2 Infection and Protection Against Future Variants Including Omicron in Adolescents: National, Prospective Cohort StudyFelicity Aiano, Georgina Ireland, Frances Baawuah, et al.
Archives of Disease in Childhood|July 8, 2024
An open-label, phase IV randomised controlled trial of two schedules of a four-component meningococcal B vaccine in UK preterm infantsAnna Calvert, Nick Andrews, Sheula Barlow, et al.
The Lancet. Infectious Diseases|August 19, 2018
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled studyWilbur H Chen, Kathleen M Neuzil, C Rebecca Boyce, et al.
Human Vaccines & Immunotherapeutics|November 28, 2022
Presentations at the UK National Immunisation ConferenceAndrew J Pollard, Noni E MacDonald, Eve Dubé, et al.
Vaccine|October 10, 2020
Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolatesAlessia Biolchi, Gabriella De Angelis, Monica Moschioni, et al.
The Journal of Infection|November 5, 2019
Prevention and control of meningococcal disease: Updates from the Global Meningococcal Initiative in Eastern EuropeXilian Bai, Ray Borrow, Suzana Bukovski, et al.
Emerging Infectious Diseases|July 5, 2008
A prospective study of etiology of childhood acute bacterial meningitis, TurkeyMehmet Ceyhan, Inci Yildirim, Paul Balmer, et al.
Expert Review of Vaccines|November 9, 2016
The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protectionRay Borrow, Pedro Alarcón, Josefina Carlos, et al.
Pageof 41